[Polypeptide vessel complex and its role in physiology function regulation in aging pathology.]

Area of Science:

• Biochemistry
• Pharmacology
• Gerontology

Background:

• Age-related cardiovascular diseases pose a significant health burden.
• Existing treatments often have limitations in efficacy and side effects.
• Novel therapeutic agents targeting vascular health are needed.

Purpose of the Study:

• To review the therapeutic potential of Slavinorm® (Vasolin), a polypeptide vessel complex from calf aorta.
• To evaluate Slavinorm®'s effects on age-related cardiovascular pathologies in animal models.
• To explore Slavinorm®'s impact on various physiological systems relevant to aging and disease.

Main Methods:

• Extraction and characterization of polypeptide complex from calf aorta.
• Administration of Slavinorm® to animal models with induced age-related pathologies.
• Assessment of various biomarkers including lipid metabolism, immune function, coagulation, and fibrinolysis.
• Evaluation of Slavinorm®'s effects on vessel wall integrity and repair mechanisms.

Main Results:

• Slavinorm® demonstrated significant therapeutic effects in animal models of cardiovascular aging.
• It effectively prevented atherosclerosis and normalized lipid metabolism and peroxidation.
• The complex positively influenced immune status, the kallikrein-kinin system, hemostasis, and fibrinolysis.
• Slavinorm® also activated vessel wall repair and showed benefits in other age-related diseases like arthritis and pancreatitis.

Conclusions:

• Slavinorm® exhibits broad therapeutic potential for age-related cardiovascular diseases.
• Its multifaceted action includes anti-atherosclerotic, metabolic, immunomodulatory, and pro-regenerative effects.
• Further research into Slavinorm® could lead to novel treatments for age-related pathologies.